Source BioScience’s has launched a DNA sequencing service at its German laboratory that it claims can process samples from clinical trial patients and return data to sponsors and CROs in as little as three hours.
Outsourcing-pharma.com presents a roundup of deals in the contract research space with acquisitions by Aptiv and Eurofins, another partnership for Spaulding and fundraising by Clinipace.
Solvias and RohnerChem have set up a research and manufacturing services partnership designed to accelerate the production, scale-up and commercialisation of APIs.
The contract research sector has grown markedly over the last decade, with more drugs being examined in more trials by more researchers according to a new Association of Clinical Research Organisations (ACRO) survey.
State-border delays, tolls and paperwork are increasing logistics costs in India and making transit less efficient than the EU and China, a report found.
Communication was the central theme at Patient Recruitment Outsourcing (PRO) 2011 in Boston, US this week, with attendees agreeing that better dialog between all stakeholders is vital to addressing the trial sector’s perennial recruitment headache.
Early adopters are effectively using social media for patient recruitment and retention but in general the industry is fearful, a panelist at Patient Recruitment Outsourcing (PRO) 2011 said.
The EU Clinical Trials Register (EU-CTR) has been formally recognised by the World Health Organization (WHO) as one of the primary registries for its International Clinical Trials Registry Platform (ICTRP).
Anti-cancer clinical trial specialist, South Texas Accelerated Therapeutics (START), has collaborated with China's largest cancer hospital to open a new Phase I cancer research center.
Clinical trial enrollment can be accelerated by better understanding patients and using EHRs to inform protocol design, panelists told an Outsourcing-Pharma conference.
Cambridge Major Laboratories Europe (CMLE) is set to start commercial API manufacturing at its facility in the Netherlands after approval by Dutch regulators.
Novozymes has achieved a successful supply chain and risk mitigation strategy through implementing its own policy with chemicals company SAFC, says Luke Dimasi.
A new study claims that almost 60 per cent of clinical trial protocols for new drugs are amended during the trial, but one-third of those changes could have been avoided.
Kellman Pharmaceutical Services (KPS) and trial management services firm Y-Prime have put pen to paper in a deal to develop a series of clinical electronic monitor visit reporting (e-MVR) tools.
Ukraine's parliament, the Verkhovna Rada, has voted unanimously in favour of new legislation which will criminalise the production and trafficking of counterfeit drugs.
The Outsourcing-pharma.com team is heading to Boston, Massachusetts for Patient Recruitment Outsourcing – our exciting new US conference and networking event.